Revenio Group Oyj (REG1V) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 591 Million ()

P/E

36.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.02

Return on Equity

16.97%

Price to Book

5.42

Revenue and Profits:

Net Sales:

26 Million

(Quarterly Results - Jun 2025)

Net Profit:

3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

45.15%

6 Months

45.15%

1 Year

45.15%

2 Years

61.68%

3 Years

80.79%

4 Years

160.74%

5 Years

233.26%

Revenio Group Oyj for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.13%

EBIT Growth (5y)

7.34%

EBIT to Interest (avg)

22.40

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.10

Sales to Capital Employed (avg)

0.84

Tax Ratio

24.71%

Dividend Payout Ratio

57.51%

Pledged Shares

Institutional Holding

ROCE (avg)

30.11%

ROE (avg)

21.01%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.25

EV to EBIT

23.95

EV to EBITDA

20.54

EV to Capital Employed

6.42

EV to Sales

6.07

PEG Ratio

Dividend Yield

ROCE (Latest)

26.81%

ROE (Latest)

17.34%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 4.33% vs 13.90% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -24.39% vs 28.12% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.50",
          "val2": "25.40",
          "chgp": "4.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.20",
          "val2": "7.00",
          "chgp": "2.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.10",
          "val2": "4.10",
          "chgp": "-24.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "230.20%",
          "val2": "204.70%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.14% vs -0.41% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.14% vs -12.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "103.50",
          "val2": "96.60",
          "chgp": "7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.90",
          "val2": "30.10",
          "chgp": "-0.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.80",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.50",
          "val2": "19.10",
          "chgp": "-3.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "238.60%",
          "val2": "270.50%",
          "chgp": "-3.19%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

26.50

25.40

4.33%

Operating Profit (PBDIT) excl Other Income

7.20

7.00

2.86%

Interest

1.70

0.00

Exceptional Items

0.00

Consolidate Net Profit

3.10

4.10

-24.39%

Operating Profit Margin (Excl OI)

230.20%

204.70%

2.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 4.33% vs 13.90% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -24.39% vs 28.12% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

103.50

96.60

7.14%

Operating Profit (PBDIT) excl Other Income

29.90

30.10

-0.66%

Interest

0.70

0.80

-12.50%

Exceptional Items

0.00

Consolidate Net Profit

18.50

19.10

-3.14%

Operating Profit Margin (Excl OI)

238.60%

270.50%

-3.19%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 7.14% vs -0.41% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -3.14% vs -12.39% in Dec 2023

All Annual Results

Company CV

About Revenio Group Oyj

Revenio Group Oyj

Pharmaceuticals & Biotechnology

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

Company Coordinates

Company Details

Ayritie 22 , VANTAA None : 01510

Tel: 358 9 87751150

https://www.reveniogroup.fi/

Registrar Details